Analyst Ratings January 27, 2026

Argus Lifts Monster Beverage Price Target to $95 Citing Growth Across Markets

Analyst keeps Buy rating as firm points to sustained revenue expansion, strong margins and a clean balance sheet

By Leila Farooq MNST
Argus Lifts Monster Beverage Price Target to $95 Citing Growth Across Markets
MNST

Argus upgraded its 12-month price objective for Monster Beverage to $95 from $90 and reaffirmed a Buy rating, highlighting the company’s ability to expand sales domestically and internationally, robust profitability and a strong balance sheet. The move joins a wave of analyst increases in recent weeks and underscores continued bullishness on energy drinks and Monster’s market position.

Key Points

  • Argus raised its Monster Beverage price target to $95 and kept a Buy rating
  • Monster shows strong historical growth and profitability but trades at a premium valuation
  • Multiple analysts have also increased targets, reflecting sector-wide optimism

Argus on Tuesday increased its 12-month price target for Monster Beverage Co. to $95.00 from $90.00 while leaving its rating on the stock at Buy. The new target implies upside from Monster’s then-current share price of $81.16, with the stock trading close to a 52-week high of $83.24.

In its rationale, Argus pointed to Monster’s capacity to grow revenue in both the United States and international markets as the principal driver behind the higher target. The research firm called attention to the company’s historical expansion, citing five-year compound annual sales and earnings-per-share growth rates in the 13% to 15% range. That view is consistent with Monster’s reported 12% revenue compound annual growth rate over the past five years and a total shareholder return of 64.49% over the last 12 months.

Argus also flagged the company’s conservative financial position. The company carries more cash than debt and shows a healthy current ratio of 3.19, indicators that support operational flexibility and resilience. While the firm acknowledged that Monster’s valuation carries a premium - noting that the stock trades at a price-to-earnings ratio of 46.3 and is above its assessed fair value - Argus argued that the premium is justified by ongoing product launches and enhancements that bolster future growth potential.

The analyst report highlighted the strategic importance of the energy drinks category to Monster’s outlook, stressing that the segment remains a fast-growing portion of the beverage market. Monster’s gross profit margin, reported at 55.81%, was singled out as a competitive advantage that helps the company capture value in a crowded industry. Argus further noted management’s efforts to capture share and lift margins across fast-expanding emerging markets.

Maintaining a long-term, five-year Buy rating, Argus reinforced its constructive stance on Monster’s trajectory. With a market capitalization of $79.3 billion, the company continues to rank among the larger players in the global beverage sector.

Other equity research desks have recently moved in a similar direction. Morgan Stanley raised its price target for Monster to $96 and held an Overweight rating. Stifel increased its target to $82, citing expectations of "advantaged growth" in the U.S. energy drink market alongside continued international expansion, and reiterated its Buy rating. Piper Sandler set a $85 target, pointing to robust top-line momentum particularly in the company’s zero sugar offerings. Wells Fargo raised its target to $83 after an upbeat annual meeting and maintained an Overweight stance.

Collectively, these adjustments by multiple analysts reflect a broadening consensus that Monster’s combination of product innovation, margin strength and balance sheet health supports continued growth. The recent string of upward adjustments underscores investor and analyst focus on the energy drinks category as a growth engine within the consumer staples and beverages sectors.


Summary

Argus raised its price target on Monster Beverage to $95 from $90 while keeping a Buy rating. The analyst emphasized the company’s domestic and international revenue growth potential, healthy margins and a strong balance sheet as reasons for the upgrade. The move aligns with other recent analyst increases and signals widespread optimism about Monster’s prospects in the energy drinks market.

Key points

  • Argus moved its price target to $95 and retained a Buy rating; the stock was trading near $81.16 and close to a 52-week high of $83.24.
  • Monster has shown a five-year revenue CAGR of 12% and delivered a 64.49% return over the past 12 months; five-year compound sales and EPS growth rates are cited at 13% to 15%.
  • Financial position and profitability - cash exceeding debt, a current ratio of 3.19, and a gross margin of 55.81% - underpin the bullish outlook; however, the stock trades at a rich P/E of 46.3.

Risks and uncertainties

  • Valuation risk - Monster’s reported P/E of 46.3 is above its stated fair value, indicating sensitivity to any slowdown in growth or margin pressure; this affects equities in the consumer staples and beverage sectors.
  • Competitive and market risk - while management aims to improve share and margins in emerging markets, execution risk in international expansion could impact top-line forecasts and investor expectations in the consumer discretionary and beverage markets.

Risks

  • Valuation is rich with a P/E of 46.3, increasing sensitivity to growth or margin setbacks
  • Execution risk in expanding market share and margins in emerging markets could affect revenue trajectories

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026